Next, we studied the expression levels of MEG8 and SNORD112 in a panel of three different breast cancer cell lines: T47D, MDA-MB-468 and MDA-MB-231; and we also include the non-tumorigenic cell line of epithelial breast tissue MCF10A. This evidence concerns the gene MEG8 and breast carcinoma.